Abstract
Pulsatile secretion of cortisol (F) has not been documented in the newborn infant. Using repeated blood sampling and deconvolution analysis, we investigated F secretion and elimination dynamics in a group of five premature (gestational age, 24-34 weeks) and five term neonates. These infants had required placement of an umbilical arterial cannula for monitoring respiratory status, but were otherwise clinically stable. Blood samples were obtained at 15-min intervals for a 6-h period. All plasma F determinations were 58 nmol/L (2.1 μg/dL) or more, and pulsatile F secretion was observed in all infants. No significant differences were noted between the two groups with regard to 6-h mean plasma F concentration [350 ± 129 (premature) vs. 277 ± 54 nmol/L (term)], plasma corticosteroid-binding globulin (14 ± 0 vs. 13 ± 1 mg/L), F secretory burst frequency (4 ± 0 vs. 5 ± 1 bursts/6 h), mass of F secreted per burst [760 ± 480 vs. 310 ± 100 nmol/Lv [Lv, liter of F distribution volume)], F production rate (FPR; 2.7 ± 1.4 vs. 1.1 ± 0.2 μmol/Lv·6 h), or plasma F half-life (45 ± 6 vs. 56 ± 4 min). However, the premature infants had a significantly longer F secretory burst half-duration (63 ± 18 vs. 6.7 ± 4.0 min; P < 0.01) and a significantly lower maximal F secretory rate (9.4 ± 3.4 vs. 100 ± 26 nmol/Lv·min; P < 0.02) than the term infants. Body surface area and body weight were inversely correlated with F secretory burst half-duration (r = -0.74 and -0.75, respectively); both were also positively correlated with the maximal F secretory rate (r = 0.66 and 0.72). The two most premature infants had significantly greater mean plasma F and FPR than the other three premature and all of the term infants. Extrapolating to 24 h and correcting for the distribution volume of F and body surface area, we estimate FPR to be approximately 17-24 μmol/m2·24 h (6.6-8.8 mg/m2·24 h) for newborn infants of 34 weeks or more gestational age. These values are consistent with newer estimates of FPR in older children and adults determined using either deconvolution analysis or stable isotope dilution methods.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 458-463 |
| Number of pages | 6 |
| Journal | Journal of Clinical Endocrinology and Metabolism |
| Volume | 77 |
| Issue number | 2 |
| State | Published - Aug 1993 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Biochemistry
- Endocrinology, Diabetes and Metabolism
Cite this
Characterization of pulsatile secretion and clearance of plasma cortisol in premature and term neonates using deconvolution analysis. / Metzger, Daniel L.; Wright, Nancy M.; Veldhuis, Johannes D; Rogol, Alan D.; Kerrigan, James R.
In: Journal of Clinical Endocrinology and Metabolism, Vol. 77, No. 2, 08.1993, p. 458-463.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Characterization of pulsatile secretion and clearance of plasma cortisol in premature and term neonates using deconvolution analysis
AU - Metzger, Daniel L.
AU - Wright, Nancy M.
AU - Veldhuis, Johannes D
AU - Rogol, Alan D.
AU - Kerrigan, James R.
PY - 1993/8
Y1 - 1993/8
N2 - Pulsatile secretion of cortisol (F) has not been documented in the newborn infant. Using repeated blood sampling and deconvolution analysis, we investigated F secretion and elimination dynamics in a group of five premature (gestational age, 24-34 weeks) and five term neonates. These infants had required placement of an umbilical arterial cannula for monitoring respiratory status, but were otherwise clinically stable. Blood samples were obtained at 15-min intervals for a 6-h period. All plasma F determinations were 58 nmol/L (2.1 μg/dL) or more, and pulsatile F secretion was observed in all infants. No significant differences were noted between the two groups with regard to 6-h mean plasma F concentration [350 ± 129 (premature) vs. 277 ± 54 nmol/L (term)], plasma corticosteroid-binding globulin (14 ± 0 vs. 13 ± 1 mg/L), F secretory burst frequency (4 ± 0 vs. 5 ± 1 bursts/6 h), mass of F secreted per burst [760 ± 480 vs. 310 ± 100 nmol/Lv [Lv, liter of F distribution volume)], F production rate (FPR; 2.7 ± 1.4 vs. 1.1 ± 0.2 μmol/Lv·6 h), or plasma F half-life (45 ± 6 vs. 56 ± 4 min). However, the premature infants had a significantly longer F secretory burst half-duration (63 ± 18 vs. 6.7 ± 4.0 min; P < 0.01) and a significantly lower maximal F secretory rate (9.4 ± 3.4 vs. 100 ± 26 nmol/Lv·min; P < 0.02) than the term infants. Body surface area and body weight were inversely correlated with F secretory burst half-duration (r = -0.74 and -0.75, respectively); both were also positively correlated with the maximal F secretory rate (r = 0.66 and 0.72). The two most premature infants had significantly greater mean plasma F and FPR than the other three premature and all of the term infants. Extrapolating to 24 h and correcting for the distribution volume of F and body surface area, we estimate FPR to be approximately 17-24 μmol/m2·24 h (6.6-8.8 mg/m2·24 h) for newborn infants of 34 weeks or more gestational age. These values are consistent with newer estimates of FPR in older children and adults determined using either deconvolution analysis or stable isotope dilution methods.
AB - Pulsatile secretion of cortisol (F) has not been documented in the newborn infant. Using repeated blood sampling and deconvolution analysis, we investigated F secretion and elimination dynamics in a group of five premature (gestational age, 24-34 weeks) and five term neonates. These infants had required placement of an umbilical arterial cannula for monitoring respiratory status, but were otherwise clinically stable. Blood samples were obtained at 15-min intervals for a 6-h period. All plasma F determinations were 58 nmol/L (2.1 μg/dL) or more, and pulsatile F secretion was observed in all infants. No significant differences were noted between the two groups with regard to 6-h mean plasma F concentration [350 ± 129 (premature) vs. 277 ± 54 nmol/L (term)], plasma corticosteroid-binding globulin (14 ± 0 vs. 13 ± 1 mg/L), F secretory burst frequency (4 ± 0 vs. 5 ± 1 bursts/6 h), mass of F secreted per burst [760 ± 480 vs. 310 ± 100 nmol/Lv [Lv, liter of F distribution volume)], F production rate (FPR; 2.7 ± 1.4 vs. 1.1 ± 0.2 μmol/Lv·6 h), or plasma F half-life (45 ± 6 vs. 56 ± 4 min). However, the premature infants had a significantly longer F secretory burst half-duration (63 ± 18 vs. 6.7 ± 4.0 min; P < 0.01) and a significantly lower maximal F secretory rate (9.4 ± 3.4 vs. 100 ± 26 nmol/Lv·min; P < 0.02) than the term infants. Body surface area and body weight were inversely correlated with F secretory burst half-duration (r = -0.74 and -0.75, respectively); both were also positively correlated with the maximal F secretory rate (r = 0.66 and 0.72). The two most premature infants had significantly greater mean plasma F and FPR than the other three premature and all of the term infants. Extrapolating to 24 h and correcting for the distribution volume of F and body surface area, we estimate FPR to be approximately 17-24 μmol/m2·24 h (6.6-8.8 mg/m2·24 h) for newborn infants of 34 weeks or more gestational age. These values are consistent with newer estimates of FPR in older children and adults determined using either deconvolution analysis or stable isotope dilution methods.
UR - http://www.scopus.com/inward/record.url?scp=0027182794&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027182794&partnerID=8YFLogxK
M3 - Article
VL - 77
SP - 458
EP - 463
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
SN - 0021-972X
IS - 2
ER -